Works matching DE "AMLODIPINE/VALSARTAN"

Results: 18

mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats.

Published in:

Clinical & Experimental Hypertension, 2017, v. 39, n. 8, p. 754, doi. 10.1080/10641963.2017.1324480

By:

Potucek, Peter;
Radik, Michal;
Doka, Gabriel;
Kralova, Eva;
Krenek, Peter;
Klimas, Jan

Publication type:

Article

Efficacy and Tolerability of a Single-Pill Combination of Amlodipine/Valsartan in Asian Hypertensive Patients Not Adequately Controlled with Valsartan Monotherapy.

Published in:

Clinical & Experimental Hypertension, 2011, v. 33, n. 3, p. 179, doi. 10.3109/10641963.2010.531849

By:

Huang, Jun;
Sun, Ning-Ling;
Hao, Yu-Ming;
Zhu, Jun-Ren;
Tu, Yingmei;
Curt, Valentin;
Zhang, Ying

Publication type:

Article

Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension.

Published in:

International Journal of Hypertension, 2021, p. 1, doi. 10.1155/2021/6695744

By:

Aabed, Wafa' J.;
Radwan, Asma H.;
Zaid, Abdel Naser;
Shraim, Naser Y.

Publication type:

Article

Combination of AML/VAL leads to overall 28.5% reduction in SBP and 13.5% reduction in DBP-Somia Iqtidar.

Published in:: Pulse International, 2020, v. 21, n. 19, p. 1
Publication type:: Article

A comprehensive guidelines-based approach reduces cardiovascular risk in everyday practice: the VARO study.

Published in:

2017

By:

Štulc, Tomáš;
Lánská, Věra;
Šnejdrlová, Michaela;
Vrablík, Michal;
Prusíková, Martina;
Češka, Richard

Publication type:

journal article

Mixed amlodipine/valsartan overdose treated by the molecular adsorbent recirculating system (MARS™).

Published in:

Clinical Toxicology (15563650), 2015, v. 53, n. 6, p. 573, doi. 10.3109/15563650.2015.1050594

By:

Gérard, Ludovic;
Galloy, Anne-Cécile;
Capron, Arnaud;
Hantson, Philippe

Publication type:

Article

To compare anti-albumin urea effects of valsartan alone with combination of valsartan and amlodipine in patients of chronic kidney disease.

Published in:

Pakistan Journal of Medical Sciences, 2016, v. 32, n. 3, p. 613, doi. 10.12669/pjms.323.9541

By:

Ameen;
Kashif, Muhammad Ali;
Sumreen

Publication type:

Article

Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.

Published in:

2015

By:

Machnicki, G.;
Ong, S.H.;
Chen, W.;
Wei, Z.J.;
Kahler, K.H.

Publication type:

journal article

Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.

Published in:

Current Medical Research & Opinion, 2014, v. 30, n. 10, p. 1937, doi. 10.1185/03007995.2014.942415

By:

Sison, Jorge;
Assaad-Khalil, Samir Helmy;
Najem, Robert;
Kitchlew, Asad Riaz;
Cho, Belong;
Ueng, Kwo-Chang;
Shete, Abhijit;
Knap, Ditte

Publication type:

Article

APOL1 variants may induce HIV-associated nephropathy during HIV primary infection.

Published in:

2017

By:

De Laroche, Marine;
Desbuissons, Geoffroy;
Rouvier, Philippe;
Barin, Francis;
Deray, Gilbert;
Caumes, Eric;
Katlama, Christine;
Tubiana, Roland;
Bagnis, Corinne Isnard;
Isnard Bagnis, Corinne

Publication type:

journal article

Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 6, p. 1557, doi. 10.1111/bcp.13082

By:

Heo, Young ‐ A;
Holford, Nick;
Kim, Yukyung;
Son, Mijeong;
Park, Kyungsoo

Publication type:

Article

Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin–Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study.

Published in:

American Journal of Hypertension, 2018, v. 31, n. 9, p. 995, doi. 10.1093/ajh/hpy078

By:

Fujiwara, Takeshi;
Yano, Yuichiro;
Hoshide, Satoshi;
Kanegae, Hiroshi;
Hashimoto, Junichiro;
Kario, Kazuomi

Publication type:

Article

Tardive akathisia related to the antihypertensive agent Sevikar-a case report.

Published in:

2017

By:

Men-Ting Hsieh;
Pao-Yen Lin;
Chia-Jen Tsai;
Chiung-Chih Chang;
Yu Lee

Publication type:

Case Study

Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study.

Published in:

Drugs - Real World Outcomes, 2016, v. 3, n. 3, p. 307, doi. 10.1007/s40801-016-0082-5

By:

Assaad-Khalil, Samir;
Nashaat, Nashwa

Publication type:

Article

Antiphospholipid syndrome presenting as chronic venous insufficiency in a young male.

Published in:

Archives of Rheumatology, 2021, v. 36, n. 4, p. 615, doi. 10.46497/ArchRheumatol.2021.8515

By:

Khan, Marium Marufia;
Zafar, Amara;
Shahid, Sana

Publication type:

Article

A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2013, v. 13, n. 5, p. 301, doi. 10.1007/s40256-013-0033-4

By:

Ferdinand, Keith;
Nasser, Samar

Publication type:

Article

Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1670, doi. 10.1111/dom.13282

By:

Yang, Ye Seul;
Lim, Min Hyuk;
Lee, Seong Ok;
Roh, Eun;
Ahn, Chang Ho;
Kwak, Soo Heon;
Cho, Young Min;
Kim, Sungwan;
Mari, Andrea;
Park, Kyong Soo;
Jung, Hye Seung

Publication type:

Article

Simultaneous densitometric analysis of amlodipine, hydrochlorothiazide, lisinopril, and valsartan by HPTLC in pharmaceutical formulations and human plasma.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2017, v. 40, n. 9, p. 467, doi. 10.1080/10826076.2017.1324482

By:

Pandya, Jui J.;
Sanyal, Mallika;
Shrivastav, Pranav S.

Publication type:

Article